CIDRAP newsletters options
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
In vaccine news, Moderna looks to having phase 3 trial results before December.
A single student was the likely source of an outbreak that infected 76% of attendees.
Yesterday the Centers for Disease Control and Prevention (CDC) reported two separate Escherichia coli O157:H7 outbreaks in the United States. Neither has an identified source, and one has already proved deadly.
A study yesterday in Science reports that the vast majority of patients with mild-to-moderate COVID-19 have stable levels of antibodies for at least 5 months.
In recent weeks Europe has become one of the world's biggest pandemic hot spots.
Many facilities have less than 1 week's supply of at least one type of protective equipment.
"Cases are actually going up. And we know that, too, because hospitalizations are going up."
A Swedish study in The Lancet Healthy Longevity yesterday revealed a higher risk of COVID-19 mortality among older people—ages 70 and above—living in nursing homes as well as with or in close contact with younger people, underlining the importance of community spread and individual points of transmission to older adults.
Officials in several nations are announcing or considering sweeping new restrictions.
Any flu vaccine delays have been largely due to the rate of delivery, not the supply.
A panel of experts convened by the International Society for Infectious Diseases (ISID) has released a set of recommendations for preventing Clostridioides difficile infections in hospitals in low- and middle-income countries (LMICs).
Sports cardiologists in JAMA Cardiology yesterday updated guidance for athletes returning to play (RTP) after COVID-19 infection. The authors recommended a risk stratification approach, with screening for cardiac injury only for athletes with severe disease or preexisting cardiovascular (CV) conditions.
A day after the most daily cases ever, the global total tops 43 million infections.
Also, severity of disease may be predictive of longer-lasting antibody protection.
A top White House official says the nation can't control COVID-19.
The data suggest avoidance of care for fear of infection or for other reasons, even for life-threatening conditions.
A multicenter survey found that only 7% of ambulatory healthcare settings in the United States have fully functional antimicrobial stewardship programs (ASPs), researchers reported late last week in Open Forum Infectious Diseases.
New data from the Centers for Disease Control and Prevention (CDC) show that US healthcare workers accounted for 6% of COVID-19 hospitalizations from March through May.
Vaccination rates are steady, though disparities remain for the uninsured.
